PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer
Giorgio Ivan Russo(European Association of Urology), Giuseppe Broggi(University of Catania), Giuseppe Morgia(University of Catania), Marina Di Mauro(University of Catania), Arturo Lo Giudice(University of Catania), Stefania Stefani(University of Catania), Paolo Giuseppe Bonacci(University of Catania), Mariacristina Massimino(University of Catania), Massimo Camarda, Maria Giovanna Asmundo(University of Catania), Rosario Caltabiano(University of Catania), Nicolò Musso(Università degli Studi di Enna Kore), Elisabetta Pricoco(University of Catania), Dalida Bivona(University of Catania), Sebastiano Cimino(University of Catania), Matteo Ferro(European Institute of Oncology)
Cited by 7
Related Papers
European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility
|European Urology|2021|612
CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1
|Cancers|2019|230
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Surgical Treatment of Spasticity in Cerebral Palsy
|Pediatric Neurosurgery|1978|166